Published in Naunyn Schmiedebergs Arch Pharmacol on February 01, 1985
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand. Br J Pharmacol (1987) 1.09
Effects of Bay K 8644 on contraction of the human isolated bronchus and guinea-pig isolated trachea. Br J Pharmacol (1986) 0.98
Interaction of palmitoyl carnitine with calcium antagonists in myocytes. Br J Pharmacol (1989) 0.95
The effects of Bay K 8644 and nifedipine on the neural responses of the rabbit ear artery. Br J Pharmacol (1986) 0.84
Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferens. Br J Pharmacol (1989) 0.82
Selective antagonism of calcium channel activators by fluspirilene. Br J Pharmacol (1990) 0.81
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev (1996) 13.17
Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.84
Antagonism of adenosine 5'-triphosphate-induced relaxation by 2-2'-pyridylisatogen in the taenia of guinea-pig caecum. Br J Pharmacol (1975) 1.68
A functional correlate for the dihydropyridine binding site in rat brain. Nature (1985) 1.68
Activators and inactivators of Ca++ channels: new perspectives. J Pharmacol (1986) 1.29
Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.24
Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol (1990) 1.23
Identification of separate receptors for adenosine and adenosine 5'-triphosphate in causing relaxations of the isolated taenia of the guinea-pig caecum. Br J Pharmacol (1976) 1.22
Proceedings: 2-2' pyridylisatogen tosylate: an antagonist of the inhibitory effects of ATP on smooth muscle. Br J Pharmacol (1974) 1.15
Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle. Br J Pharmacol (1983) 1.14
Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists. Br J Pharmacol (1984) 1.09
The mechanism of the relaxant effect of 2-2'-pyridylisatogen on the isolated taenia of the guinea-pig caecum. Br J Pharmacol (1978) 1.06
BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II. Eur J Neurosci (2004) 1.05
The influence of the initial stretch and the agonist-induced tone on the effect of basal and stimulated release of EDRF. Br J Pharmacol (1990) 1.03
Calcium channel activation does not increase release of endothelial-derived relaxant factors (EDRF) in rat aorta although tonic release of EDRF may modulate calcium channel activity in smooth muscle. J Cardiovasc Pharmacol (1987) 1.01
The presence of -adrenoceptors in the guinea-pig seminal vesicle. Br J Pharmacol (1972) 1.00
(8a alpha,12a alpha,13a alpha)-5,8,8a,9,10,11,12,12a,13,13a-decahydro- 3-methoxy-12-(methylsulfonyl)-6H-isoquino[2,1-g][1,6]naphthyridi ne, a potent and highly selective alpha 2-adrenoceptor antagonist. J Med Chem (1989) 0.98
Differences between the effects of calcium antagonists in the pithed rat preparation. J Cardiovasc Pharmacol (1983) 0.97
Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry (2011) 0.97
[3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site. Br J Pharmacol (1989) 0.96
Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol (1999) 0.96
Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF? Br J Pharmacol (2014) 0.96
Alpha 2-adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol Sci (1994) 0.96
Interaction of palmitoyl carnitine with calcium antagonists in myocytes. Br J Pharmacol (1989) 0.95
Characterisation of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2. Biochim Biophys Acta (1995) 0.95
Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide. Br J Pharmacol (1990) 0.95
Vasodilation by medroxalol mediated by beta 2-adrenergic receptor stimulation. J Cardiovasc Pharmacol (1983) 0.95
"Calcium antagonists": a class of drugs with a bright future. Part II. Determination of basic pharmacological properties. Life Sci (1984) 0.95
Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine. J Cardiovasc Pharmacol (1993) 0.94
Mitochondria as target for antiischemic drugs. Adv Drug Deliv Rev (2001) 0.92
The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil. Br J Pharmacol (1993) 0.92
Anatagonism of the inhibitory effects of adenosine 5'-triphosphate on the isolated taenia of the guinea-pig caecum: structure-activity relationships within a series of isatogen derivatives. Br J Pharmacol (1978) 0.91
Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptors. J Med Chem (1991) 0.90
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther (1998) 0.90
The low-frequency blood oxygenation level-dependent functional connectivity signature of the hippocampal-prefrontal network in the rat brain. Neuroscience (2012) 0.90
[3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification. Br J Pharmacol (1992) 0.90
Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites. J Cardiovasc Pharmacol (1987) 0.90
GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986. Cell Death Differ (2009) 0.89
"Calcium antagonists": a class of drugs with a bright future. Part I. Cellular calcium homeostasis and calcium as a coupling messenger. Life Sci (1983) 0.89
Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor. Br J Pharmacol (1996) 0.88
Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase. Br J Pharmacol (1993) 0.88
The problems associated with the use of 2,2'-pyridylisatogen tosylate in evaluating the allegedly purinergic innervation of peripheral organs. J Pharm Pharmacol (1978) 0.88
Antagonism of Ca2+-induced contractions of K+-depolarized smooth muscle by local anaesthetics. Eur J Pharmacol (1985) 0.88
Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635. Br J Pharmacol (1997) 0.87
[3H]p-aminoclonidine and [3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur J Pharmacol (1993) 0.87
S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J Pharmacol Exp Ther (1997) 0.86
The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants. Eur J Pharmacol (2001) 0.86
RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors. Br J Pharmacol (1995) 0.86
Interaction of phorbol esters with Ca2+ channels in smooth muscle. Br J Pharmacol (1987) 0.86
Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil. Br J Pharmacol (1999) 0.86
Stereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors. J Pharm Pharmacol (1982) 0.84
The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine. Br J Pharmacol (1989) 0.84
Modulation of central noradrenergic function by RS-15385-197. Br J Pharmacol (1993) 0.84
Functional interactions of calcium-antagonists in K+-depolarized smooth muscle. Br J Pharmacol (1983) 0.84
Calcium antagonist properties of diclofurime isomers. I. Functional aspects. J Cardiovasc Pharmacol (1987) 0.84
Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings]. Br J Pharmacol (1979) 0.83
Sodium modulation of 3H-agonist and 3H-antagonist binding to alpha 2-adrenoceptor subtypes. Br J Pharmacol (1993) 0.82
The effects of 2-2'-pyridylisatogen tosylate on the electrical activity of smooth muscle of the isolated taenia caeci of the guinea-pig [proceedings]. Br J Pharmacol (1978) 0.81
Selective antagonism of calcium channel activators by fluspirilene. Br J Pharmacol (1990) 0.81
2-2'-Pyridylisatogen, a selective allosteric modulator of P2 receptors, is a spin trapping agent. Biochem Biophys Res Commun (1998) 0.81
Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology (1999) 0.81
Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule. Mol Psychiatry (2012) 0.81
Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology (2003) 0.80
Differential effects of non-peptidic tachykinin receptor antagonists on Ca2+ channels. Eur J Pharmacol (1994) 0.80
A one-step synthesis of 2-(2-Pyridyl)-3H-indol-3-one N-oxide: is it an efficient spin trap for hydroxyl radical? J Org Chem (2000) 0.79
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther (1995) 0.79
Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions. Neuropharmacology (2001) 0.79
S 14506: novel receptor coupling at 5-HT(1A) receptors. Neuropharmacology (2001) 0.79
Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197). Br J Pharmacol (1996) 0.79
Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia. Br J Pharmacol (1995) 0.78
Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors. J Neural Transm (Vienna) (1997) 0.78
Identification of a novel calcium antagonist binding site in rat brain by SR 33557. Br J Pharmacol (1993) 0.78
S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. J Pharmacol Exp Ther (1998) 0.78
Pertussis toxin-sensitive G-protein activation does not influence the response to Bay K 8644 in embryonic chick myocytes. J Cardiovasc Pharmacol (1990) 0.78
MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia. J Cardiovasc Pharmacol (1987) 0.77
Differential effects of calcium channel antagonists on histamine and pentagastrin-stimulated gastric acid secretion in the rat. Agents Actions (1985) 0.77
Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase. J Cardiovasc Pharmacol (1980) 0.77
Cerebral ischaemia reduces the density of 5-HT2 binding sites in the frontal cortex of the gerbil. Neuropharmacology (1988) 0.77
Mitochondrial pharmacology: energy, injury and beyond. Br J Pharmacol (2014) 0.76
The alpha 2-adrenoceptor antagonist SK&F 104078 has high affinity for 5-HT1A and 5-HT2 receptors. Eur J Pharmacol (1989) 0.76
Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro. J Cardiovasc Pharmacol (2001) 0.76
Interactions of palmitoyl carnitine with the endothelium in rat aorta. Br J Pharmacol (1990) 0.75
Effects of metoclopramide and isoprenaline in the rat vas deferens; interactions with alpha-adrenoceptors. Br J Pharmacol (1980) 0.75
Neural control of dieting. Nature (1996) 0.75
A modified guinea-pig stomach preparation [proceedings]. Br J Pharmacol (1977) 0.75
The guinea-pig ileum preparation as a model for 5-HT1A receptors: anomalous effects with RS-30199-193. Br J Pharmacol (1991) 0.75
S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur J Pharmacol (1994) 0.75
Changes in [3H]-PK 11195 and [3H]-8-OH-DPAT binding following forebrain ischaemia in the gerbil. Br J Pharmacol (1993) 0.75
Receptor classification and nomenclature: the revolution and the resolution. Trends Pharmacol Sci (1994) 0.75
Paired vasa deferentia: a method of reducing variability in the response to drugs. Arch Int Pharmacodyn Ther (1974) 0.75
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors. Eur J Pharmacol (1994) 0.75
1,9-Alkano-bridged 2,3,4,5-tetrahydro-1H-3-benzazepines with affinity for the alpha 2-adrenoceptor and the 5-HT1A receptor. J Med Chem (1990) 0.75
Quantitative analysis of the dihydropyridines, 3-(2-furoyl)-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)- 1,4-dihydropyridine and nifedipine, by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1986) 0.75
Nomenclature of calcium channels and channel modulators: IUPHAR classification. J Cardiovasc Pharmacol (1993) 0.75
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. Pharmacol Rev (1994) 0.75
Acylation differentiates two forms of agonist binding to rat 5-HT1A receptors. Palmitoylated G protein--agonist states? Ann N Y Acad Sci (1997) 0.75
IUPHAR guidelines for classification of new receptor-subtypes. Int J Clin Pharmacol Ther (1995) 0.75
Comparison between the effects of MDL 72567 and nifedipine on various cardiovascular parameters in conscious sinoaortic-denervated rats and sham-operated controls. J Cardiovasc Pharmacol (1987) 0.75